25 of the Best Hematologists Near Me

Adam M. Brufsky, MD, PhD, FACP, is professor of medicine at the University of Pittsburgh School of Medicine and also serves as the associate division chief for the Division of Hematology/Oncology at the University of Pittsburgh School of Medicine's Department of Medicine. Dr. Brufsky is the medical director of the Magee-Women's Cancer Program, part of the UPMC Hillman Cancer Center, and UPMC Hillman Cancer Center; associate director for clinical investigations at UPMC Hillman Cancer Center; and codirector of the Comprehensive Breast Cancer Center.Dr. Brufsky is board-certified in internal medicine and medical oncology. He earned a medical and doctor of philosophy degrees from the University of Connecticut School of Medicine in Farmington, Conn.; completed a residency at Brigham and Women's Hospital, Harvard Medical School, and a fellowship at Dana-Farber Cancer Institute.Dr. Brufsky is a member of professional organizations, such as American Medical Association, Massachusetts Medical Society, American College of Physicians, American Society of Clinical Oncology, American Association for Cancer Research, Allegheny County Medical Society, Pennsylvania Medical Society, and Pennsylvania Oncologic Society. An active researcher, Dr. Brufsky has numerous abstracts and research articles in leading journals, and is principal investigator on a number of research grants funded by the National Institutes of Health, Susan G. Komen Foundation, and US Army - Breast Cancer Research Program. Dr. Brufsky is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Breast Cancer, Triple-Negative Breast Cancer, Inflammatory Breast Cancer, Breast Cancer in Men, and Gastrostomy. Dr. Brufsky is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine. Dr. Brufsky is currently accepting new patients.

Priyanka Pophali is a Hematologist practicing medicine in Madison, Wisconsin. Dr. Pophali is highly rated in 16 conditions, according to our data. Her clinical expertise encompasses Non-Hodgkin Lymphoma, Mantle Cell Lymphoma (MCL), B-Cell Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Pophali is board certified in Hematology, Internal Medicine, and Medical Oncology. Dr. Pophali is currently accepting new patients.

Dr. Vlachos is the chief of hematology in the Johns Hopkins All Children’s Hospital Cancer & Blood Disorders Institute in St. Petersburg, Florida, and professor of pediatrics (PAR) in the Johns Hopkins University School of Medicine. She joined the hospital staff in 2024. She was previously professor of pediatrics at Zucker School of Medicine at Hofstra/Northwell and attending physician in hematology/oncology at Cohen Children’s Medical Center/Northwell Health, where she was head of the Bone Marrow Failure Program and head of the pediatric hematology/oncology trials office. Dr. Vlachos is internationally known for clinical care and expertise in bone marrow failure syndromes and her transformational research in Diamond Blackfan anemia (DBA) syndrome, a rare inherited bone marrow failure syndrome. Dr. Vlachos is the founder and has directed the Diamond Blackfan Anemia Registry (DBAR) of North America since its inception in 1991. She is the principal investigator and co-investigator on multiple grants funded by the National Institute of Health and the Centers for Disease Control and Prevention. She has published numerous articles on her research findings and has been invited to author papers and book chapters on bone marrow failure syndromes and DBA. Dr. Vlachos is a member of the Medical and Scientific Advisory Board for the Shwachman-Diamond Syndrome Registry, is a member of the Scientific Advisory Board for the Diamond Blackfan Anemia Foundation and holds a position on the Scientific Program Committee for Bone Marrow Failure of the American Society of Hematology. She earned her medical degree from New York Medical College in Valhalla, New York. She completed her residency in pediatrics at North Shore University Hospital in Manhasset, New York. She then completed a clinical fellowship in bone marrow transplantation at North Shore University Hospital, followed by a fellowship in pediatric hematology-oncology and bone marrow transplantation at Mount Sinai Medical Center in New York. Videos Bone Marrow Failure Syndrome Expert Dr. Adrianna Vlachos at Johns Hopkins All Children’s. Dr. Vlachos is highly rated in 15 conditions, according to our data. Her clinical expertise encompasses Aase Syndrome, Pure Red Cell Aplasia, Aplastic Anemia, and Transient Erythroblastopenia of Childhood. Dr. Vlachos is board certified in American Board Of Pediatrics. Dr. Vlachos is currently accepting new patients.

Evan Alley is a Hematologist Oncology provider practicing medicine in Stuart, Florida. Dr. Alley is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Mesothelioma, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Metastatic Pleural Tumor. Dr. Alley is board certified in American Board Of Internal Medicine, 2002. Dr. Alley is currently accepting new patients.

Aziz Nazha is a Hematologist and a Hematologist Oncology provider practicing medicine in Sewell, New Jersey. Dr. Nazha is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML), Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Nazha is board certified in Hematology/Oncology and Medical Oncology. Dr. Nazha is currently accepting new patients.

I specialize in the treatment of gastrointestinal (GI) cancers with a focus on clinical trials. Clinical trial patients can come to me at any point during their disease, but they usually come to me looking for an alternative therapy once standard treatments have not been effective. I decided to become a doctor later in my career. I originally graduated from university with a non-science degree, but the excitement of advancing medical breakthroughs inspired me to start a career in medicine. As a Duke physician, I enjoy the diverse experiences that I get to have each week. In addition to taking care of patients and conducting research, I work closely with other doctors on crafting treatment plans. I also find it fulfilling to be able to apply my research to patient care. In my spare time, I enjoy spending time with my family, jogging and skiing. Dr. Strickler is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Pancreatic Cancer, Stomach Cancer, and Familial Colorectal Cancer. Dr. Strickler is board certified in American Board Of Internal Med, Internal Medicine and American Board Of Internal Med, Medical Oncology. Dr. Strickler is currently accepting new patients.

Veena John, MD, is the System Head for GYN/Medical Oncology for the Northwell Health Cancer Institute and an Assistant Professor of Medicine in the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Board certified in Internal Medicine, Hematology and Medical Oncology, she maintains an active practice caring for patients with gynecologic cancers where she focuses on providing compassionate, personalized, evidence-based multi-disciplinary care. In conjunction with physicians in Surgical Oncology, she pioneered a multi-disciplinary team approach for gynecologic oncology patients at the R.J. Zuckerberg Cancer Center where her practice is based. Dr. John is a highly experienced principal investigator for industry sponsored Phase I, II and III clinical trials in gynecologic oncology. She is the site principal investigator for the NRG cooperative group for the Northwell Health Cancer Institute and co-chair of the protocol review monitoring committee. Dr. John earned her medical degree from Christian Medical College in India, where she also completed her internal medicine internship. She completed her internal medicine residency at Flushing Medical Center and fellowship in hematology and medical oncology at North Shore University Hospital. She is an active member of the Society for Gynecologic Oncology, Society for Immunotherapy in Cancer, American Society of Clinical Oncology and American Society of Hematology as well as a member of the Ovarian Cancer committee for the national Gynecologic Oncology Group. Dr. John is highly rated in 15 conditions, according to our data. Her clinical expertise encompasses Ovarian Cancer, Endometrial Cancer, Testicular Yolk Sac Tumor, and Malignant Mixed Mullerian Tumor. Dr. John is board certified in American Board Of Internal Medicine/Medical Oncology, American Board Of Internal Medicine, and American Board Of Internal Medicine/Hematology. Dr. John is currently accepting new patients.

Timothy Carey is a Hematologist Oncology provider practicing medicine in Braselton, Georgia. Dr. Carey is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Paget Disease of the Breast, Inflammatory Breast Cancer, Multiple Myeloma, and Lung Cancer. Dr. Carey is board certified in American Board Of Internal Medicine, Hematology - 2007. Dr. Carey is currently accepting new patients.

Dr. Sreeram Maddipatla is a triple-board-certified oncologist and hematologist with the Orlando Health Cancer Institute Liver Center and Pancreas Center. His specialties include: Colon cancer Pancreatic cancer Stomach and esophageal cancer Liver cancer Lymphoma Prostate cancer Bladder cancer Testicular cancer Lung cancer Breast cancer Benign hematology such as anemias Dr. Maddipatla strives to care for each patient the way he would want to be treated. Dr. Maddipatla's Training Dr. Maddipatla received his medical training at Sri Devaraj Urs Medical College in Bangalore, India, and his Master of Public Health (MPH) from the University of North Texas Health Science Center at Fort Worth. He completed an internal medicine residency at the State University of New York in Buffalo and a fellowship in hematology and oncology at MD Anderson Cancer Center in Orlando. About Dr. Maddipatla Dr. Maddipatla is board certified in internal medicine, hematology and oncology by the American Board of Internal Medicine. His professional memberships include the American College of Physicians, American Society of Clinical Oncology and American Society of Hematology. Dr. Maddipatla has presented his research at national conferences and has published articles in peer-reviewed journals, including Clinical Cancer Research and Oncology. He has also received several awards, like Outstanding Master's in Public Health (MPH) student award at the University of North Texas, Fort Worth, Texas, recipient of the Dinah Kukes Cancer Memorial Fund Grant, Exemplary Physician Colleague award from Orlando Health and the Golden Apple Award - Practice of Medicine Preceptor award for excellence in teaching from the University of Central Florida. Dr. Maddipatla also contributes to the American Board of Internal Medicine as a question writer for hematology board exams. Outside of work, he enjoys tennis, traveling and reading. Dr. Maddipatla is fluent in English, Hindi and Telugu. Dr. Maddipatla is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Familial Colorectal Cancer, Colorectal Cancer, Sickle Cell Disease, and Prostate Cancer. Dr. Maddipatla is board certified in American Board Of Internal Medicine - Hematology, American Board Of Internal Medicine, and American Board Of Internal Med. - Medical Oncology. Dr. Maddipatla is currently accepting new patients.

Christine L Hann, completed her MD and Ph.D. at Jefferson Medical College/Thomas Jefferson University follwed by an internal medicine residency at the University of Chicago Hospitals. Following a fellowship at Johns Hopkins University in Hematology and Oncology, Dr. Hann joined the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center as a member of the Upper Aerodigestive Cancer Program and sees patients with non-small cell and small cell lung cancer. Dr. Hann's research focus is on developing novel therapeutics for lung cancer, particularly small cell lung cancer (SCLC) and neuroendocrine tumors (NETs) such as carcinoid tumors of the lung. As a faculty member she is involved in both clinical and laboratory research. Specific research projects include: 1) Studying mechanisms of resistant to small molecule inhibitors of the antiapoptotic protein, BCL-2 using patient-derived xenograft models. Her preclinical work has led to an NCI-sponsored Phase 1/2 clinical trial combining a BCL-2 inhibitor with a TORC1/2 inhibitors which is currently underway (NCT03366103). 2) Preclinical evaluation of various therapeutics including epigenetic modulators (LSD1 inhibitors) and nanoliposome chemotherapy in SCLC PDXs; 3) Modeling and characterizing chemoradiotherapy resistance in preclinical models of SCLC. She, along with Dr. Luigi Marchionni in Biostatistics and Dr. Phuoc Tran in the Department of Radiation Oncology, were recently awarded a 5-year NCI-sponsored U01 grant to study mechanisms of chemoradiation resistance in SCLC. Dr. Hann is PI of several trials in SCLC and NSCLC and is leading investigator-initiated clinical trials in SCLC and NETs. Dr. Hann is highly rated in 14 conditions, according to our data. Her clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Squamous Cell Lung Carcinoma. Dr. Hann is board certified in American Board Of Internal Medicine. Dr. Hann is currently accepting new patients.

Peter Voorhees is a Hematologist and an Oncologist practicing medicine in Charlotte, North Carolina. Dr. Voorhees is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Smoldering Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Voorhees is board certified in American Board Of Internal Medicine, Hematology. Dr. Voorhees is currently accepting new patients.

Gulam Manji, M.D., Ph.D. is an Associate Professor of Medicine at Columbia University Medical Center. Dr. Manji received his M.D. degree from Ross University School of Medicine in 2009 and completed his residency in internal medicine at Albany Medical College. He then completed his fellowship in Hematology/Oncology at NewYork-Presbyterian/Columbia, where his clinical focus was on the treatment of gastrointestinal malignancies, melanoma, and sarcoma under the mentorship of Dr. Gary Schwartz, Chief of Hematology and Oncology.Dr. Manji conducts translational research with the overall goal to developing new treatments for cancer. His focus is in gastrointestinal malignancies, particularly pancreas adenocarcinoma, on which he is conducting preclinical combination immunotherapy studies on genetically engineered mice with pancreas cancer in the Olive laboratory at the Herbert Irving Comprehensive Cancer Center. The combination immunotherapy preclinical proposal received the Young Investigator Award from the American Society of Clinical Oncology-2015. The goal of these preclinical studies is to bring promising new therapies to the clinic in an early phase clinical trials Dr. Manji's research career in identifying new genes and their implication in disease has led to numerous key publications and an issued patent.Dr. Manji cares for patients with gastrointestinal malignancies, with a particular focus on pancreatic and liver cancers, and sarcomas. He is the principal investigator of an investigator-initiated multicenter clinical trial that he wrote with Dr. Gary Schwartz in sarcoma and malignant peripheral nerve sheath tumors and is responsible for clinical trials conducted in liver, bile duct, gallbladder, and pancreas cancers at Columbia University Medical Center. Dr. Manji is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Malignant Peripheral Nerve Sheath Tumor, Familial Pancreatic Cancer, and Pancreatectomy. Dr. Manji is board certified in Internal Medicine and Medical Oncology. Dr. Manji is currently accepting new patients.

Craig Seaman is a Hematologist practicing medicine in Pittsburgh, Pennsylvania. Dr. Seaman is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Von Willebrand Disease (VWD), Hemophilia A, Blood Clots, and Hemophilic Arthropathy. Dr. Seaman is board certified in American Board Of Internal Medicine. Dr. Seaman is currently accepting new patients.

Shams Bufalino is a Hematologist and an Oncologist practicing medicine in Park Ridge, Illinois. Dr. Bufalino is highly rated in 14 conditions, according to our data. Her clinical expertise encompasses Large-Cell Immunoblastic Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Hodgkin Lymphoma, Classical Hodgkin Lymphoma, and Bone Marrow Aspiration. Dr. Bufalino is board certified in American Board Of Internal Medicine, Hematology. Dr. Bufalino is currently accepting new patients.

Liza C. Villaruz, MD, is board-certified in medical oncology and hematology at UPMC Hillman Cancer Center, and she specializes in lung cancer and thoracic malignancies. Dr. Villaruz is highly rated in 13 conditions, according to our data. Her clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, EGFR Positive Lung Cancer, and Small Cell Lung Cancer (SCLC). Dr. Villaruz is board certified in American Board Of Internal Medicine. Dr. Villaruz is currently accepting new patients.

Shira Dinner is a Hematologist and an Oncologist practicing medicine in Chicago, Illinois. Dr. Dinner is highly rated in 13 conditions, according to our data. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Dinner is board certified in American Board Of Internal Medicine - Hematology (Certified). Dr. Dinner is currently accepting new patients.

Asad Sheikh, MD, a board-certified medical oncologist, serves as the director of oncology at Orlando Health Cancer Institute at South Seminole Hospital. Dr. Sheikh joined Orlando Health Cancer Institute from the Medical College of Georgia where he served as chief fellow of the hematology/oncology fellowship program. He is board certified in hematology, medical oncology and internal medicine. After joining Orlando Health Cancer Institute in Lake Mary, Dr. Sheikh singlehandedly developed a comprehensive community medical oncology and hematology program including inpatient and outpatient oncology clinics as well as an infusion center serving Seminole county.Dr. Sheikh earned his medical degree from Allama Iqbal Medical College in Pakistan and completed an internship for the Department of Surgery and Medicine at Services Hospital in Pakistan the following year.He worked at the Radiotherapy Clinics of Georgia in Decatur, GA, where he was a clinical research physician and awarded permanent residency in the United States under the special category of Outstanding Professor/Researcher in the Field of Cancer. Dr. Sheikh went on to complete his internship and residency in internal medicine at the University of Florida in Gainesville, FL. Dr. Sheikh has a license to practice medicine in California, Florida, Georgia and Pakistan. He is a member of several organizations, including the American Society of Clinical Oncology, the American Society of Hematology and Oncology and the Patient Welfare Society.Dr. Sheikh has published several studies for the American Society of Clinical Oncology and presented the second largest data trial published in the U.S. on breast cancer in the community setting.Dr. Sheikh also designed, developed and maintained MS Access and SQL databases for cancer patients. His research has been featured in national and international scientific assemblies such as the American Society of Clinical Oncology, the American Society for Radiation Oncology, the British Oncologic Association and the San Antonio Breast Cancer Symposium. Dr. Sheikh is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Squamous Cell Lung Carcinoma, Lung Adenocarcinoma, Small Cell Lung Cancer (SCLC), and ALK-Positive Non-Small Cell Lung Cancer. Dr. Sheikh is board certified in American Board Of Osteopathic IM - Medical Onc and American Board Of Internal Medicine. Dr. Sheikh is currently accepting new patients.

Shamila Garg is a Hematologist and an Oncologist practicing medicine in Evergreen Park, Illinois. Dr. Garg is highly rated in 13 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Prostate Cancer. Dr. Garg is board certified in American Board Of Internal Medicine. Dr. Garg is currently accepting new patients.

Craig Hofmeister is a Hematologist Oncology provider practicing medicine in Atlanta, Georgia. Dr. Hofmeister is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Smoldering Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Hofmeister is board certified in American Board Of Internal Medicine, 2005. Dr. Hofmeister is currently accepting new patients.

Kathryn Mileham is a Hematologist and an Oncologist practicing medicine in Charlotte, North Carolina. Dr. Mileham is highly rated in 12 conditions, according to our data. Her clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, EGFR Positive Lung Cancer, and Small Cell Lung Cancer (SCLC). Dr. Mileham is board certified in American Board Of Internal Medicine, Medical Oncology. Dr. Mileham is currently accepting new patients.

Dr. Pulsipher is currently the Division Chief of the Pediatric Hematology at Intermountain Primary Children's Hospital and Oncology, Director of the Children's and Adolescent Cancer Initiative at Huntsman Cancer Institute and a Presidential Chair in Pediatric Oncology and Hematology at the University of Utah.  Dr. Pulsipher is an internationally recognized expert in Bone Marrow Transplantation and Cellular Therapy, having directed the world's largest pediatric transplant research group for more than a decade (Pediatric Transplantation and Cellular Therapy Consortium).  He has run more than 20 multicenter trials in the field and is considered and expert in broad areas of transplantation and cellular therapy.  Areas of focus have included development of reduced toxicity approaches to transplantation of both malignant and non-malignant disorders with a focus on minimizing short and long-term effects of transplant.  For non-malignant disorders he has run national protocols that have improved safety for patients with immunodeficiencies, HLH, and bone marrow failure. For cancer, he has developed techniques allowing identification of patients who can avoid radiation-based treatments for leukemia.  This has included a novel approach to safer transplantation of patients using half-matched family donors (haploidentical donors) using a novel form of bone marrow graft engineering called alpha-beta T-cell depletion.  His desire to develop safer approaches has become a major focus as he has led major studies in the field of chimeric antigen receptor T-cells (CAR T-cells), a safer approach to cancer cure.  Dr. Pulsipher's work in cell therapy helped lead to the FDA approval of the first CART cell treatment, tisagenlecleucel, and he continues to run trials in CAR T, NK, and Viral Specific T-cell therapies. He has open protocols aimed at improving outcomes and his lab efforts are focused on making CAR T-cells that last longer and avoid overcome resistance by cancer cells. Dr. Pulsipher's interests have included ensuring that the families of those undergoing transplantation and cell therapy are psychologically well throughout the process.  To help with this, he has run several large trials assessing the safety and Quality of Life of pediatric bone marrow donors and is he currently running a large national trial looking at the psychological well-being of donor and recipient families as they go through the transplant process.For questions regarding Dr. Pulsipher's adult practice at the Huntsman Cancer Institute, or for questions about any of our clinical programs and for assistance identifying the right Hematology specialist for you or your family member, please contact our Clinical Care Specialist/New Patient Coordinator at (801) 587-4652. For questions regarding Dr. Pulsipher's pediatric practice and the Blood and Marrow Transplant Program at Primary Children's Medical Center, please call (801) 662-4830. Dr. Pulsipher is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL), Graft Versus Host Disease (GvHD), Leukemia, Aplastic Anemia, and Bone Marrow Transplant. Dr. Pulsipher is board certified in American Board Of Pediatrics. Dr. Pulsipher is currently accepting new patients.

David Vanderweele is a Hematologist and an Oncologist practicing medicine in Chicago, Illinois. Dr. Vanderweele is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Non-Muscle Invasive Bladder Cancer, Muscle Invasive Bladder Cancer, and Prostatectomy. Dr. Vanderweele is board certified in American Board Of Internal Medicine - Medical Oncology (Certified). Dr. Vanderweele is currently accepting new patients.

Dr. Sekwon Jang is a specialty care physician board certified in internal medicine, hematology, and medical oncology. He has a special interest in management of melanoma and other skin cancers including cutaneous lymphoma. Dr. Jang serves as Director of Melanoma and Cutaneous Oncology Therapeutics and Research and Director of Quality at the Inova Schar Cancer Institute. Before joining Inova, Dr. Jang served as Assistant Professor of Medicine at Georgetown University School of Medicine and Co-Chair of melanoma research group at MedStar Georgetown Cancer Network. Dr. Jang believes in a covenant relationship with his patients, and his goal is to provide the best quality patient-centered care in the setting of multidisciplinary collaboration. Dr. Jang is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Melanoma, Merkel Cell Carcinoma, Cutaneous T-Cell Lymphoma (CTCL), and Squamous Cell Skin Carcinoma. Dr. Jang is currently accepting new patients.

Prasad Kudalkar is a Hematologist and an Oncologist practicing medicine in Fairfield, Ohio. Dr. Kudalkar is highly rated in 112 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), and Lymphofollicular Hyperplasia. Dr. Kudalkar is board certified in American Board Of Internal Medicine. Dr. Kudalkar is currently accepting new patients.

Dr. Waqas Jehangir specializes in blood & bone marrow transplant at Avera Medical Group Hematology, Transplant & Cellular Therapy in Sioux Falls, SD. Dr. Jehangir is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance (MGUS), Chronic B-Cell Leukemia (CBCL), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Jehangir is board certified in American Board Of Internal Medicine Fellow Of The American College Of Physicians (FACP) Hematology Board Certified Oncology Board Certified Hospice And Palliative Medicine Board Certified. Dr. Jehangir is currently accepting new patients.